The Investigation of the Effect of Electrolyte Disorder on Sweat Test in Newborns with Positive Cystic Fibrosis Screening
Öz
Background and objectives: The aim of this study is to investigate the effect of the electrolyte and acid-base status present at the time of admission to the hospital on the sweat test (ST) of the patients who were found to have a positive newborn screening test (NST) for Cystic Fibrosis (CF).
Methods: The patients who referred to pediatric pulmonology clinic for ST with positive NST for CF and diagnosed as CF were analyzed retrospectively. From the medical records acid-base status measured simultaneously with the ST and with serum sodium, potassium, and chloride levels were included in the study.
Results: The study completed with 37 patients who met the inclusion criteria. At the time of ST, the mean sodium, potassium and chlorine values were 134.83±4.25 (122.0-141.0), 4.94±0.95 (2.9-7.6) and 97.72±12.40 (64.0-116.0) mEq/L, respectively. Patients whose electrolytes were measured at the time of diagnosis, 27.0% (n=10) had hyponatremia, 8.1% (n=3) had hypokalemia, and 4.8% (n=1) had hypochloremia. There was a significant difference between serum chloride and bicarbonate levels according to the negative, borderline, positive ST groups (p=0,036). In addition, no significance detected between the sweat test values of patients with Pseudo-Bartter Syndrome (PBS) (38.7%) and without.
Conclusion: The chloride level during ST is lower in patients with borderline and negative ST results. The mean potassium and chloride values of the patients with PBS are lower while the mean bicarbonate value is higher. This may cause false negative results in ST. So, it is important to check the serum electrolyte levels before the ST is performed in the newborn screening positive baby.
Anahtar Kelimeler
cystic fobrosis, sweat test, newborn screening, serum electrolytes, pseudo Bartter syndome
Etik Beyan
The study was approved by the Ethics Committee of Necmettin Erbakan University Meram Medical Faculty (Number: 2019/1826 Date: 10.05.2019).
Kaynakça
- Gadsby DC, Vergani P, Csanády L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 2006; 440: 477-83. https://doi.org/10.1038/nature04712
- Gillion V, Jadoul M, Devuyst, Pochet JM. The patient with metabolic alkalosis. Acta Clin Belg.2019; 74: 34-40. https://doi.org/10.1080/17843286.2018.1539373
- Candemir M, Semiz S, Ozdemir OM. Pseudo-Bartter's Syndrome in Patient with Cystic Fibrosis. Turk J Pediatr. 2008; 17: 194-197. DOİ: 10.5222/terh.2016.090
- Kintu B, Brightwell A. Episodic seasonal Pseudo Bartter syndrome in cystic fibrosis. Paediatr Respir Rev. 2014; 15: 19-21. https://doi.org/10.1016/j.prrv.2014.04.0155.
- Yalçin E, Kiper N, Doğru D, Ozçelik U, Aslan AT. Clinical features and treatment approaches in cystic fibrosis with pseudo-Bartter syndrome. Ann Trop Paediatr. 2005; 25: 119-24. https://doi.org/10.1179/146532805X45719
- Sismanlar Eyuboglu T, Dogru D, Çakır E, Cobanoglu N, Pekcan S, Cinel G et al. Clinical features and accompanying findings of Pseudo Bartter Syndrome in cystic fibrosis. Pediatr Pulmonol. 2020; 55: 2011-6. https://doi.org/10.1002/ppul.24805
- Yee J. Bartter Syndrome. In: Ferri FF. Editor. Ferri's Clinical Advisor E-Book: 5 Books in Elsevier Health Sciences. 2020 pp: 211.e6-211.e7https://www.clinicalkey.com/#!/content/book/3-s2.0B9780323672542001030?scrollTo=%23hl0000098
- T.R. Public Health Agency of Turkey Ministry of Health, the National Newborn Screening Program of the Cystic Fibrosis Screening Sweat Test Guide 2015.
- T.R. Public Health Agency of Turkey Ministry of Health, Neonatal Metabolic and Endocrine Disease Screening Program (NSP), CF flow chart. https://hsgm.saglik.gov.tr/tr/cocukergen-tp-liste/yenidogan_tarama_programi.html
- Egan M. Cystic Fibrosis. In: Kliegman RM, Stanton BF, Geme JW, Schor NF, Behrman RE (Eds). Nelson Textbook of Pediatrics. 19th Edition, Philadelphia; Elsevier Saunder. 2011 pp 1481-1497.